Inhaled study drug for moderate to severe copd
Part of Lungs & breathing clinical trials.
This trial tests an inhaled medication (given through a nebulizer) to see how well it improves breathing and quality of life in people with moderate-to-severe COPD. It may help reduce symptoms and flare-ups, but will require regular visits and lung function tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 40 and 80 years old.
- You must have a diagnosis of moderate to severe COPD, confirmed by a breathing test (FEV1/FVC ratio below 0.7 and FEV1 between 30% and 80% of predicted).
- You must have at least some breathlessness during daily activities (mMRC score of 1 or more).
- You must be a past or current smoker (at least 10 pack-years, e.g., 1 pack a day for 10 years) or have a history of exposure to biomass fuels (like wood or dung smoke).
- Your COPD must be stable — no major flare-ups in the last 4 weeks (for new participants) and no steroid treatment or hospital stays for COPD in the last 3 months.
- You must be able to use a nebulizer correctly and follow the study schedule.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an inhaled medication that may help improve breathing and reduce flare-ups in people with moderate-to-severe COPD. If you qualify, you'll use the study drug through a nebulizer at home and have regular check-ups to see how it works.
This study tests an oral tablet called RSS0343 for people with moderate to severe COPD. It aims to see if the tablet can improve lung function and reduce flare-ups when added to your current breathing treatments.
This study tests a new combination inhaler (fluticasone, formoterol, and glycopyrronium) for people with COPD. It aims to see if this triple therapy can improve breathing and quality of life compared to current treatments.
This trial tests an inhaled medication for COPD. It aims to see if the treatment is safe and helps improve breathing and symptoms.
This trial tests an investigational drug called TQC2731 for people with severe asthma that is not well controlled despite high-dose inhaled steroids. The study aims to see if this treatment can reduce asthma attacks.
This study tests an inhaled medication called RB042 in healthy adults, healthy smokers, and people with COPD. It aims to see how the drug works in the body and whether it is safe, which could help in developing a new treatment for COPD.
Hear when a new Chronic Obstructive Pulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.